Tag: Pediatric
LogicBio Therapeutics: Potential breakthrough in the Treatment of Methylmalonic Acidemia (MMA).
LogicBio Therapeutics (NASDAQ: LOGC), a gene-editing company that uses its GeneRide technology platform to develop solutions for rare diseases in pediatric patients was recently...
Emerging treatment approaches in Pruritus
Pruritus is characterized by an uncomfortable and persistent urge to scratch caused either due to a skin disorder or an underlying systemic disease such...
We are looking for talented interns to learn and help investors find valuable companies.